Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

PubWeight™: 2.96‹?› | Rank: Top 1%

🔗 View Article (PMC 2193336)

Published in J Exp Med on January 15, 2001

Authors

T A Fehniger1, K Suzuki, A Ponnappan, J B VanDeusen, M A Cooper, S M Florea, A G Freud, M L Robinson, J Durbin, M A Caligiuri

Author Affiliations

1: Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

Articles citing this

(truncated to the top 100)

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med (2002) 5.64

Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50

NK cell development, homeostasis and function: parallels with CD8⁺ T cells. Nat Rev Immunol (2011) 3.38

Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J Clin Invest (2006) 3.27

Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med (2007) 3.05

Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci U S A (2008) 2.60

Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med (2003) 2.51

Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity (2012) 2.23

T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J Exp Med (2001) 2.16

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A (2003) 2.07

Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01

Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. Blood (2010) 1.77

Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med (2009) 1.70

The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol (2010) 1.67

Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci (2011) 1.64

Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett (2009) 1.64

Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A (2001) 1.60

Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol (2011) 1.47

Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates. Blood (2010) 1.41

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues. PLoS One (2016) 1.39

Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab (2008) 1.38

Immune memory redefined: characterizing the longevity of natural killer cells. Immunol Rev (2010) 1.36

Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood (2007) 1.32

NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest (2011) 1.30

IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood (2010) 1.29

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A (2009) 1.28

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest (2010) 1.28

Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine. J Immunol (2005) 1.26

{gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells. Proc Natl Acad Sci U S A (2005) 1.21

Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood (2006) 1.19

Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity (2012) 1.18

IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci U S A (2001) 1.16

A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J Exp Med (2006) 1.15

Regulation of mouse NK cell development and function by cytokines. Front Immunol (2013) 1.14

Homeostatic maintenance of T cells and natural killer cells. Cell Mol Life Sci (2012) 1.13

In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol (2010) 1.09

Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. J Biomed Biotechnol (2011) 1.09

NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol (2005) 1.08

Regulating the immune system via IL-15 transpresentation. Cytokine (2012) 1.08

Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood (2006) 1.06

Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.05

Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr (2010) 1.04

Cutting edge: the role of IFN-α receptor and MyD88 signaling in induction of IL-15 expression in vivo. J Immunol (2012) 1.03

Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res (2009) 1.02

Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood (2013) 0.98

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood (2005) 0.97

One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci (2013) 0.97

The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood (2008) 0.96

Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95

Functions of IL-15 in anti-viral immunity: multiplicity and variety. Cytokine (2012) 0.94

Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα. Blood (2011) 0.93

Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood (2006) 0.93

IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells. J Immunol (2008) 0.93

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res (2016) 0.93

Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice. J Immunol (2013) 0.92

Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes. Nat Immunol (2005) 0.90

Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res (2014) 0.90

IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner. Proc Natl Acad Sci U S A (2013) 0.90

Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin. Infect Immun (2004) 0.90

Misregulated posttranscriptional checkpoints: inflammation and tumorigenesis. J Exp Med (2001) 0.88

Natural killer cell regulation by microRNAs in health and disease. J Biomed Biotechnol (2012) 0.87

An antagonist mutant IL-15/Fc promotes transplant tolerance. Transplantation (2006) 0.87

Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86

IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells. Proc Natl Acad Sci U S A (2014) 0.86

Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy. PLoS One (2012) 0.85

Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85

IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia (2014) 0.85

A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leuk Res (2009) 0.84

CD8(+) T cells resistant to costimulatory blockade are controlled by an antagonist interleukin-15/Fc protein. Transplantation (2006) 0.84

Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model. BMC Cancer (2015) 0.83

Exercise-stimulated interleukin-15 is controlled by AMPK and regulates skin metabolism and aging. Aging Cell (2015) 0.83

Transcriptional regulation of IL-15 expression during hematopoiesis. J Immunol (2013) 0.83

Differential effects of stimulatory factors on natural killer cell activities of young and aged mice. J Gerontol A Biol Sci Med Sci (2012) 0.82

Two-compartment model of NK cell proliferation: insights from population response to IL-15 stimulation. J Immunol (2012) 0.82

Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. Am J Immunol (2009) 0.81

Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3. Mol Immunol (2008) 0.81

Tumor growth decreases NK and B cells as well as common lymphoid progenitor. PLoS One (2008) 0.81

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology (2014) 0.80

Animal models to study gluten sensitivity. Semin Immunopathol (2012) 0.80

Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity. PLoS One (2014) 0.80

Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas. Dev Biol (2012) 0.79

Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2. J Virol (2008) 0.78

Important lessons derived from animal models of celiac disease. Int Rev Immunol (2011) 0.78

Mechanistic model of natural killer cell proliferative response to IL-15 receptor stimulation. PLoS Comput Biol (2013) 0.78

Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin Immunopathol (2006) 0.78

Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma. Cancer Discov (2016) 0.77

Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine (2013) 0.77

TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF⁺ leukocytes. PLoS One (2014) 0.77

Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J Biol Chem (2015) 0.76

Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet Muscle (2015) 0.76

Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture. Inflammation (2014) 0.76

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells. Proc Natl Acad Sci U S A (2016) 0.76

Unraveling the molecular events leading to the genesis of large granular lymphocytic leukemia reveals a new treatment strategy. Haematologica (2013) 0.75

Molecular mechanisms influencing NK cell development: implications for NK cell malignancies. Am J Blood Res (2011) 0.75

Effect of exercise therapy on cytokine secretion in the saliva of bedridden patients. J Phys Ther Sci (2016) 0.75

Characterization of human T lymphocytes engineered to express interleukin-15 and herpes simplex virus-thymidine kinase. J Surg Res (2013) 0.75

Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity. Sci Rep (2017) 0.75

Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent. Cytokine Growth Factor Rev (2017) 0.75

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use. J Immunol Res (2017) 0.75

Articles cited by this

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med (2000) 9.78

Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol (1999) 9.55

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02

Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity (1998) 8.29

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity (1995) 6.91

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science (1994) 6.65

Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 6.22

Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 5.69

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20

Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06

Interleukin 15: biology and relevance to human disease. Blood (2001) 4.47

FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A (1991) 4.29

A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med (1999) 4.15

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J (1995) 3.59

Immune responses in interleukin-2-deficient mice. Science (1993) 3.29

Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol (1999) 3.18

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.79

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62

A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (1997) 2.37

Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17

Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07

Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J Immunol (1997) 1.84

Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol (1998) 1.81

Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med (1995) 1.80

Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol (1995) 1.69

Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. Immunity (1999) 1.66

At the crossroads of inflammation and tumorigenesis. J Exp Med (1999) 1.61

The 5' untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J Immunol (1998) 1.60

Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci U S A (1996) 1.51

Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood (1998) 1.51

Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med (2000) 1.50

The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med (1998) 1.49

Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation. Am J Clin Pathol (1999) 1.46

Regulated expression of a murine class I gene in transgenic mice. Mol Cell Biol (1986) 1.44

Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A (1997) 1.43

Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol (1997) 1.30

Interleukin 4 expressed in situ selectively alters thymocyte development. J Exp Med (1991) 1.25

Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol (1997) 1.24

The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J Exp Med (2000) 1.22

CD8+ T-cell clones in old mice. Immunol Rev (1997) 1.21

Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med (1997) 1.21

Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14

Effects of the deregulated expression of human interleukin-2 in transgenic mice. Int Immunol (1989) 1.04

Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo. J Immunol (2000) 1.02

A nonimmunoglobulin transgene and the endogenous immunoglobulin mu gene are coordinately regulated by alternative RNA processing during B-cell maturation. Mol Cell Biol (1998) 1.00

Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol (1999) 0.88

Large granular lymphocytosis. Haematologica (1998) 0.84

Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells. J Immunol (2000) 0.84

Articles by these authors

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59

Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol (2001) 13.98

The biology of human natural killer-cell subsets. Trends Immunol (2001) 10.10

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61

A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00

Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A (1980) 5.55

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood (2001) 5.23

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20

Interleukin 15: biology and relevance to human disease. Blood (2001) 4.47

The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37

The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurones and glial cells. Development (1997) 4.14

A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature (1998) 4.06

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res (2001) 3.66

Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58

Formation and reversion of Streptomycete protoplasts: cultural condition and morphological study. J Gen Microbiol (1974) 3.56

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res (2001) 3.51

A BAC-based physical map of the major autosomes of Drosophila melanogaster. Science (2000) 3.51

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50

Molecular structure of a gene, VMA1, encoding the catalytic subunit of H(+)-translocating adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1990) 3.47

Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol Biol Cell (2001) 3.41

Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol (1998) 3.34

Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol (1999) 3.18

Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01

An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00

Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A (2001) 2.97

Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry (2001) 2.92

Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86

Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem (1996) 2.85

Phylogenetic analysis of the coryneform bacteria by 5S rRNA sequences. J Bacteriol (1987) 2.83

Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83

Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J (1991) 2.68

Requirement of CD9 on the egg plasma membrane for fertilization. Science (2000) 2.65

Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet (1995) 2.64

Structure and physiological function of calpains. Biochem J (1997) 2.62

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62

Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem (1983) 2.58

Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell (1996) 2.53

Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? Nature (1985) 2.52

Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol (2003) 2.52

Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A (1970) 2.48

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature (1997) 2.46

A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell (1988) 2.44

Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun (1974) 2.43

PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40(phox). Nat Cell Biol (2001) 2.39

Gene cloning of chitinase A1 from Bacillus circulans WL-12 revealed its evolutionary relationship to Serratia chitinase and to the type III homology units of fibronectin. J Biol Chem (1990) 2.38

Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun (1999) 2.38

A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (1997) 2.37

Blood clearance rates of adenovirus type 5 in mice. J Gen Virol (2000) 2.36

Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev (2000) 2.35

Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J (1994) 2.33

Comparative study on adhesive performance of functional monomers. J Dent Res (2004) 2.32

Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. Am J Sports Med (1999) 2.29

Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene (2007) 2.27

Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun (1989) 2.23

Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol (1982) 2.22

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17

Characterization of pseudotype VSV possessing HCV envelope proteins. Virology (2001) 2.15

Crossed aphasia elicited by direct cortical stimulation. Neurology (2006) 2.15

Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res (2001) 2.14

Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology (1995) 2.14

Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature (1987) 2.14

Pericardial closure using fascia lata in patients undergoing pneumonectomy with pericardiectomy. Ann Thorac Surg (1998) 2.13

Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem (1990) 2.13

A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem (1990) 2.12

Cloning of nicotianamine synthase genes, novel genes involved in the biosynthesis of phytosiderophores. Plant Physiol (1999) 2.11

A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol (1997) 2.08

A second type of rat phosphoinositide-specific phospholipase C containing a src-related sequence not essential for phosphoinositide-hydrolyzing activity. J Biol Chem (1989) 2.06

Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 2.03

Human beta-hexosaminidase alpha chain: coding sequence and homology with the beta chain. Proc Natl Acad Sci U S A (1985) 2.03

The Tokyo subway sarin attack: disaster management, Part 1: Community emergency response. Acad Emerg Med (1998) 2.02

Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology (2000) 2.01

Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int (2008) 2.00

A new nomenclature for the cytoplasmic ribosomal proteins of Saccharomyces cerevisiae. Nucleic Acids Res (1997) 1.99

A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol Cell Biol (1992) 1.97

The organization of extrinsic neurons and their implications in the functional roles of the mushroom bodies in Drosophila melanogaster Meigen. Learn Mem (1999) 1.97

A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest (1999) 1.96

The SPIRAL genes are required for directional control of cell elongation in Aarabidopsis thaliana. Development (2000) 1.95

New attempt of personal identification by means of lip print. J Indian Dent Assoc (1970) 1.93

Interleukin-1beta promotes repair of the CNS. J Neurosci (2001) 1.92

Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest (1999) 1.91

Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry (1990) 1.91

Regulatory interactions of Csr components: the RNA binding protein CsrA activates csrB transcription in Escherichia coli. J Bacteriol (2001) 1.87

Localized fat collection adjacent to the intrahepatic portion of the inferior vena cava: a normal variant on CT. AJR Am J Roentgenol (1992) 1.87

Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood (1999) 1.84

Four-year water degradation of total-etch adhesives bonded to dentin. J Dent Res (2003) 1.83

Apg2p functions in autophagosome formation on the perivacuolar structure. J Biol Chem (2001) 1.82

The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci U S A (1998) 1.79

[The fecal flora of man. IV. Communication: Comparison of the newly developed method with the old conventional method for the analysis of intestinal flora (author's transl)]. Zentralbl Bakteriol Orig A (1976) 1.79

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci U S A (1999) 1.79

The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J Cell Biol (1998) 1.78

Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res (1976) 1.77

Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol (1999) 1.77